Close Menu

NEW YORK (360Dx) – Deep Lens said today that it has closed a $14 million Series A round to further expand its artificial intelligence and platform product development activities. It will also use the financing to scale its service, sales, and marketing organizations to support demand and growth for its approach to clinical trial recruitment.

The Series A closing comes three months after Columbus, Ohio-based Deep Lens completed a venture capital-led seed equity round, bringing its funding to date to $17.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.